Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v1-EN
Language English English
Date Updated 2021-01-05 2020-11-14
Drug Identification Number 02498626 02498626
Brand name ADYNOVATE ADYNOVATE
Common or Proper name Antihemophilic Factor (Recombinant), Pegylated Antihemophilic Factor (Recombinant), Pegylated
Company Name TAKEDA CANADA INC TAKEDA CANADA INC
Ingredients ANTIHEMOPHILIC FACTOR ANTIHEMOPHILIC FACTOR
Strength(s) 3000UNIT 3000UNIT
Dosage form(s) KIT POWDER FOR SOLUTION KIT POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 5mL, 3000 IU/UI 5mL, 3000 IU/UI
ATC code B02BD B02BD
ATC description VITAMIN K AND OTHER HEMOSTATICS VITAMIN K AND OTHER HEMOSTATICS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2020-12-01 2020-12-01
Actual start date 2020-12-01 2020-12-01
Estimated end date 2020-12-31 2020-12-31
Actual end date 2021-01-05
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments Resolved as of 05Jan2021
Health Canada comments